CS logo
small CS logo
University of Leipzig

Leipzig, Germany
Public university in Leipzig, Saxony
Augustuspl. 10, 04109 Leipzig

About University of Leipzig


Leipzig University, in Leipzig in the Free State of Saxony, Germany, is one of the world's oldest universities and the second-oldest university in Germany.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Fred Hutchinson Cancer Center
12
University of Leipzig
12
Boston Scientific Corporation
3
Celgene
3
Gilead Sciences
3
C. R. Bard
2
Rhythm Pharmaceuticals, Inc.
2
AGC Biologics S.p.A.
1
AO Clinical Investigation and Publishing Documentation
1
Abbott Medical Devices
1
Acacia Pharma Ltd
1
Total Rows: 63

Clinical Trials at University of Leipzig


During the past decade, University of Leipzig conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 17 clinical trials were completed, i.e. on average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55665566555544112211440055113311Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
1997-08-01
Completed
18
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
1997-09-01
2002-04-01
Completed
63
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
1999-11-01
Completed
55
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
1999-09-01
2018-10-01
Completed
76
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
2000-12-01
Completed
160
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
2001-07-01
2004-07-01
Completed
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
2001-08-01
2004-09-05
Completed
106

Rows per page:

1–93 of 93

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Leipzig" #1 sponsor was "Fred Hutchinson Cancer Center" with 12 trials, followed by "University of Leipzig" with 12 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 63 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Leipzig" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "University of Leipzig" with 4 trials as a collaborator, "European Society of Anaesthesiology" with 3 trials as a collaborator and "German Research Foundation" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 75 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFred Hutchinson CancerCenter: 12Fred Hutchinson CancerCenter: 12University of Leipzig: 12University of Leipzig: 12Boston Scientific Corporation: 3Boston Scientific Corporation: 3Celgene: 3Celgene: 3Gilead Sciences: 3Gilead Sciences: 3C. R. Bard: 2C. R. Bard: 2Rhythm Pharmaceuticals, Inc.: 2Rhythm Pharmaceuticals, Inc.: 2AGC Biologics S.p.A.: 1AGC Biologics S.p.A.: 1AO Clinical Investigationand PublishingDocumentation: 1AO Clinical Investigationand PublishingDocumentation: 1Abbott Medical Devices: 1Abbott Medical Devices: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 12National CancerInstitute (NCI): 12National Heart, Lung,and Blood Institute(NHLBI): 6National Heart, Lung,and Blood Institute(NHLBI): 6University of Leipzig: 4University of Leipzig: 4European Society ofAnaesthesiology: 3European Society ofAnaesthesiology: 3German Research Foundation: 2German Research Foundation: 2Hannover Medical School: 2Hannover Medical School: 2University Hospital Heidelberg: 2University Hospital Heidelberg: 2Aalborg University: 1Aalborg University: 1AdventHealth: 1AdventHealth: 1Alfried Krupp Krankenhaus: 1Alfried Krupp Krankenhaus: 1

Clinical Trials Conditions at University of Leipzig


According to Clinical.Site data, the most researched conditions in "University of Leipzig" are "Refractory Chronic Lymphocytic Leukemia" (9 trials), "Recurrent Adult Acute Lymphoblastic Leukemia" (7 trials), "Recurrent Adult Acute Myeloid Leukemia" (6 trials), "Recurrent Adult Hodgkin Lymphoma" (6 trials) and "Recurrent Small Lymphocytic Lymphoma" (6 trials). Many other conditions were trialed in "University of Leipzig" in a lesser frequency.

Clinical Trials Intervention Types at University of Leipzig


Most popular intervention types in "University of Leipzig" are "Drug" (41 trials), "Procedure" (28 trials), "Other" (17 trials), "Device" (15 trials) and "Radiation" (14 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Fludarabine Phosphate" (6 trials), "Mycophenolate Mofetil" (6 trials), "Peripheral Blood Stem Cell Transplantation" (6 trials) and "Total-Body Irradiation" (6 trials). Other intervention names were less common.

Clinical Trials Genders at University of Leipzig


The vast majority of trials in "University of Leipzig" are 89 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at University of Leipzig


Currently, there are NaN active trials in "University of Leipzig". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 56 completed trials in University of Leipzig, 1 suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in University of Leipzig, 10 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 30 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 30Not Applicable: 30Phase 3: 22Phase 3: 22Phase 2: 20Phase 2: 20Phase 1: 10Phase 1: 10Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 56Completed: 56Recruiting: 12Recruiting: 12Unknown status: 8Unknown status: 8Active, not recruiting: 7Active, not recruiting: 7Terminated: 6Terminated: 6Withdrawn: 2Withdrawn: 2Enrolling by invitation: 1Enrolling by invitation: 1Suspended: 1Suspended: 1